These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26634444)

  • 21. Mycobacterium ulcerans toxin, mycolactone may enhance host-seeking and oviposition behaviour by Aedes aegypti (L.) (Diptera: Culicidae).
    Sanders ML; Jordan HR; Serewis-Pond C; Zheng L; Benbow ME; Small PL; Tomberlin JK
    Environ Microbiol; 2017 May; 19(5):1750-1760. PubMed ID: 27907248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infiltrating leukocytes surround early Buruli ulcer lesions, but are unable to reach the mycolactone producing mycobacteria.
    Ruf MT; Steffen C; Bolz M; Schmid P; Pluschke G
    Virulence; 2017 Nov; 8(8):1918-1926. PubMed ID: 28873327
    [No Abstract]   [Full Text] [Related]  

  • 23. Buruli ulcer and mycolactone-producing mycobacteria.
    Nakanaga K; Yotsu RR; Hoshino Y; Suzuki K; Makino M; Ishii N
    Jpn J Infect Dis; 2013; 66(2):83-8. PubMed ID: 23514902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of Mycolactone A/B in Mycobacterium ulcerans-Infected Human Tissue.
    Sarfo FS; Phillips RO; Rangers B; Mahrous EA; Lee RE; Tarelli E; Asiedu KB; Small PL; Wansbrough-Jones MH
    PLoS Negl Trop Dis; 2010 Jan; 4(1):e577. PubMed ID: 20052267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of wild-type and mycolactone-negative mutant Mycobacterium ulcerans on skeletal muscle: IGF-1 protects against mycolactone-induced muscle catabolism.
    Dufresne SS; Frenette J
    Am J Physiol Regul Integr Comp Physiol; 2013 May; 304(9):R753-62. PubMed ID: 23485865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A newly discovered mycobacterial pathogen isolated from laboratory colonies of Xenopus species with lethal infections produces a novel form of mycolactone, the Mycobacterium ulcerans macrolide toxin.
    Mve-Obiang A; Lee RE; Umstot ES; Trott KA; Grammer TC; Parker JM; Ranger BS; Grainger R; Mahrous EA; Small PL
    Infect Immun; 2005 Jun; 73(6):3307-12. PubMed ID: 15908356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetics of mycolactone in human subcutaneous tissue during antibiotic therapy for Mycobacterium ulcerans disease.
    Sarfo FS; Phillips RO; Zhang J; Abass MK; Abotsi J; Amoako YA; Adu-Sarkodie Y; Robinson C; Wansbrough-Jones MH
    BMC Infect Dis; 2014 Apr; 14():202. PubMed ID: 24731247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant stromal tissue factor localisation and mycolactone-driven vascular dysfunction, exacerbated by IL-1β, are linked to fibrin formation in Buruli ulcer lesions.
    Hsieh LT; Dos Santos SJ; Hall BS; Ogbechi J; Loglo AD; Salguero FJ; Ruf MT; Pluschke G; Simmonds RE
    PLoS Pathog; 2022 Jan; 18(1):e1010280. PubMed ID: 35100311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterogeneity of mycolactones produced by clinical isolates of Mycobacterium ulcerans: implications for virulence.
    Mve-Obiang A; Lee RE; Portaels F; Small PL
    Infect Immun; 2003 Feb; 71(2):774-83. PubMed ID: 12540557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mycobacterium ulcerans infections cause progressive muscle atrophy and dysfunction, and mycolactone impairs satellite cell proliferation.
    Houngbédji GM; Bouchard P; Frenette J
    Am J Physiol Regul Integr Comp Physiol; 2011 Mar; 300(3):R724-32. PubMed ID: 21209381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mycolactone suppresses T cell responsiveness by altering both early signaling and posttranslational events.
    Boulkroun S; Guenin-Macé L; Thoulouze MI; Monot M; Merckx A; Langsley G; Bismuth G; Di Bartolo V; Demangel C
    J Immunol; 2010 Feb; 184(3):1436-44. PubMed ID: 20042571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cellular immunity confers transient protection in experimental Buruli ulcer following BCG or mycolactone-negative Mycobacterium ulcerans vaccination.
    Fraga AG; Martins TG; Torrado E; Huygen K; Portaels F; Silva MT; Castro AG; Pedrosa J
    PLoS One; 2012; 7(3):e33406. PubMed ID: 22413022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of an ELISA for the quantification of mycolactone, the cytotoxic macrolide toxin of Mycobacterium ulcerans.
    Warryn L; Dangy JP; Gersbach P; Gehringer M; Schäfer A; Ruf MT; Ruggli N; Altmann KH; Pluschke G
    PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008357. PubMed ID: 32589646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Mycobacterium ulcerans toxin, mycolactone, causes apoptosis in guinea pig ulcers and tissue culture cells.
    George KM; Pascopella L; Welty DM; Small PL
    Infect Immun; 2000 Feb; 68(2):877-83. PubMed ID: 10639458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mycobacterium ulcerans mycolactone interferes with adhesion, migration and proliferation of primary human keratinocytes and HaCaT cell line.
    Graziola F; Colombo E; Tiberio R; Leigheb G; Bozzo C
    Arch Dermatol Res; 2017 Apr; 309(3):179-189. PubMed ID: 28229230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunity against Mycobacterium ulcerans: The subversive role of mycolactone.
    Demangel C
    Immunol Rev; 2021 May; 301(1):209-221. PubMed ID: 33607704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mycobacterium ulcerans cytotoxicity in an adipose cell model.
    Dobos KM; Small PL; Deslauriers M; Quinn FD; King CH
    Infect Immun; 2001 Nov; 69(11):7182-6. PubMed ID: 11598099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sec61 blockade by mycolactone: A central mechanism in Buruli ulcer disease.
    Demangel C; High S
    Biol Cell; 2018 Nov; 110(11):237-248. PubMed ID: 30055020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uptake and cellular actions of mycolactone, a virulence determinant for Mycobacterium ulcerans.
    Snyder DS; Small PL
    Microb Pathog; 2003 Feb; 34(2):91-101. PubMed ID: 12623277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptional adaptation of
    Robbe-Saule M; Foulon M; Poncin I; Esnault L; Varet H; Legendre R; Besnard A; Grzegorzewicz AE; Jackson M; Canaan S; Marsollier L; Marion E
    Virulence; 2021 Dec; 12(1):1438-1451. PubMed ID: 34107844
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.